orange iconOperational Response Level: Restricted ›

Research Partnerships & Innovation

Ebola Outbreaks: Why is Winnipeg at Forefront of Challenge?

December 19, 2017

The worst Ebola virus outbreak in history began in December 2013 and Canada was there to respond with the assistance of the National Microbiology Laboratory’s (NML) Special Pathogens Section (Public Health Agency of Canada), who provided diagnostic support via numerous deployments of their mobile laboratory.
This session will be a unique opportunity to learn about the NML’s development of some of the key medical countermeasures, such as the Zmapp treatment and VSV-EBOV vaccine, that assisted the World Health Organization and Médecins Sans Frontières in their response to this unprecedented outbreak.
REGISTRATION FORM BELOW (7 seats remaining)
Event details:
Wednesday, February 7, 2018
12:00-1:00 p.m.
White Lecture Theatre, Red River College
2055 Notre Dame Ave, Winnipeg
Dr. Strong will explain how specialized training, high containment facilities, research models, and travel to remote regions of the world with mobile labs may be costly challenges, but necessary to protect Canadians from these rare but imposing infections.
Jim Strong obtained his MD and PhD from the University of Calgary and subsequently came to Winnipeg for training in Pediatrics as well as Post-Doctoral training at the National Microbiology Laboratory under Dr. Heinz Feldmann. His PhD studies included the molecular virology of Reovirus. He is currently cross-appointed to the departments of Pediatrics and Child Health, Medical Microbiology and Pediatric Infectious Diseases at the University of Manitoba well as the Head of Diagnostics and Therapeutics Division of Special Pathogens at the Public Health Agency of Canada.
He has also been a consultant to the World Health Organization (WHO) in management of Ebola and Marburg virus outbreaks in equatorial Africa. His current research interests include basic clinical pathophysiology of filoviruses in cell culture and animal systems (e.g. mouse, hamster, guinea pig and nonhuman primates), expanding diagnostic testing for Viral Hemorrhagic Fevers (VHFs) and Filovirus ecology. The aim of these studies is to better understand the mechanism of transmission and disease with the ultimate goal of developing interventions for the VHFs during human outbreaks.
[vfb id=’10’]